≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pulmonary oedema

DOID EFO Endpoint Browser PheWeb

J10_PULMOEDEMA

pulmonary edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J81
  • Hospital discharge: ICD-8 — 51910
  • Cause of death: ICD-10 — J81
  • Cause of death: ICD-8 — 51910

2 out of 7 registries used, show all original rules.

654

4. Check minimum number of events

None

654

5. Include endpoints

None

654

6. Filter based on genotype QC (FinnGen only)

654

Control definitions (FinnGen only)

Control exclude
J10_INTERSTITIUM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
J80-J84
Name in latin
Oedema pulmonum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9006 4604 4219
Only index persons 5204 2779 2425
Unadjusted period prevalence (%)
Whole population 0.13 0.13 0.12
Only index persons 0.10 0.10 0.09
Median age at first event (years)
Whole population 77.49 80.34 74.43
Only index persons 76.85 79.98 73.26

-FinnGen-

Key figures

All Female Male
Number of individuals 654 239 415
Unadjusted period prevalence (%) 0.15 0.08 0.18
Median age at first event (years) 73.35 73.78 73.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
604
Matched controls
6036
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J81
ICD-10 Finland
Pulmonary oedema
+∞
323.0
604
*
C03CA01
ATC
furosemide; systemic
7.1
99.4
475
2067
I50.9
ICD-10 Finland
Heart failure, unspecified
5.8
84.2
328
1024
I50.0
ICD-10 Finland
Congestive heart failure
6.9
78.1
230
493
I50.1
ICD-10 Finland
Left ventricular failure
7.1
57.4
155
279
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.6
51.6
218
657
WX722
NOMESCO Finland
PEEP
7.7
40.6
100
152
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.0
35.4
294
1435
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.2
33.5
238
1031
C01DA14
ATC
isosorbide mononitrate; oral
3.0
32.4
249
1135
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
31.3
278
1385
TK800
NOMESCO Finland
Hemodialysis
10.2
31.2
63
68
WX872
NOMESCO Finland
Intensive care
6.4
31.1
86
152
I25.2
ICD-10 Finland
Old myocardial infarction
4.1
29.7
130
380
C07AB07
ATC
bisoprolol; oral
2.7
28.5
392
2477
Z49.1
ICD-10 Finland
Extracorporeal dialysis
13.2
28.3
50
41
C03DA01
ATC
spironolactone; oral
3.6
28.2
147
497
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.9
27.5
60
74
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.9
26.0
61
85
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
25.7
185
783
AN1
HP
Coronary angiography
3.3
25.5
152
564
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.6
24.4
241
1229
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
23.2
117
380
ZXD05
NOMESCO Finland
Urgent procedure
2.5
22.8
241
1264
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
22.8
251
1346
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.5
22.4
117
390
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.9
22.0
97
281
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
22.0
104
320
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.4
21.4
267
1510
J96.0
ICD-10 Finland
Acute respiratory failure
11.2
20.7
39
37
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
20.5
224
1177
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.1
19.6
39
41
N18.8
ICD-10 Finland
Other chronic renal failure
5.6
19.3
58
113
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.8
19.1
86
253
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.7
19.0
157
704
R06.0
ICD-10 Finland
Dyspnoea
2.4
18.3
191
970
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.9
18.3
30
21
205
Kela drug reimbursment
Chronic hypertension
2.2
18.1
287
1777
WX730
NOMESCO Finland
Conventional respirator
8.6
18.0
39
48
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.8
17.6
130
541
C01AA05
ATC
digoxin; systemic
2.6
17.4
145
647
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
17.4
170
833
B01AA03
ATC
warfarin; systemic
2.2
17.3
232
1324
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.2
17.1
99
352
A10AE04
ATC
insulin glargine; parenteral
3.2
17.0
98
346
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
16.8
72
202
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
16.7
16
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
16.5
160
776
WX882
NOMESCO Finland
High dependency care
6.1
16.3
45
79
WX892
NOMESCO Finland
Monitored bed care
3.6
16.1
75
226
A12AA04
ATC
calcium carbonate; oral
7.3
15.9
38
55
B01AC04
ATC
clopidogrel; oral
2.4
15.8
154
746
V03AE01
ATC
polystyrene sulfonate; oral
8.9
15.7
33
39
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
15.6
137
627
A12BA01
ATC
potassium chloride; oral
3.2
15.4
87
304
ZX120
NOMESCO Finland
Intravenous
3.2
14.9
83
286
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.3
14.8
39
65
C09AA05
ATC
ramipril; oral
2.1
14.7
215
1252
WX725
NOMESCO Finland
Noninvasive ventilation
5.1
14.7
47
99
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
5.2
14.6
46
95
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
14.5
111
470
A11CC03
ATC
alfacalcidol; systemic
5.1
14.5
46
96
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
9.2
14.1
29
33
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
3.5
14.1
68
211
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.7
14.1
28
30
A10AA02
ATC
NA
4.3
14.0
52
128
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.6
14.0
49
114
L04AA06
ATC
mycophenolic acid; systemic
11.8
13.9
25
22
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
13.9
243
1518
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
16.7
13.5
21
13
A10BA02
ATC
metformin; oral
2.0
13.4
218
1315
N18.0
ICD-10 Finland
End-stage renal disease
6.6
13.4
34
54
WX704
NOMESCO Finland
Intubation
3.6
13.3
62
187
C08CA01
ATC
amlodipine; oral
1.9
13.2
270
1778
127
Kela drug reimbursment
Transplant complication
11.3
13.1
24
22
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
19.5
13.0
19
10
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.7
12.9
98
409
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
4.1
12.8
50
130
B03XA02
ATC
darbepoetin alfa; parenteral
5.9
12.7
35
62
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
3.5
12.6
59
179
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
5.6
12.6
36
67
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
12.5
12
*
J80
ICD-10 Finland
Adult respiratory distress syndrome
+∞
12.5
12
*
A10BB12
ATC
glimepiride; oral
2.6
12.5
94
394
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
12.4
220
1365
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.5
12.4
59
181
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
12.4
149
791
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.6
12.3
97
415
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
8.0
12.2
27
35
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
12.2
86
347
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
12.1
87
352
I20.09
ICD-10 Finland
Unstable angina
3.1
12.0
69
244
A10AA01
ATC
NA
6.3
12.0
31
51
I42.0
ICD-10 Finland
Dilated cardiomyopathy
5.1
11.9
37
76
C09AA02
ATC
enalapril; systemic
2.0
11.9
181
1055
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
3.6
11.8
53
156
WW500
NOMESCO Finland
Blood transfusion
4.2
11.7
44
110
C01BD01
ATC
amiodarone; systemic
4.5
11.7
41
96
Z94.0
ICD-10 Finland
Kidney transplant status
11.4
11.6
21
19
A98
ICPC
Health maint/preventive medicine
0.5
11.4
315
4014
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
11.4
69
252
196
Kela drug reimbursment
Paricalcitol and cinacalcet
15.4
11.4
18
12
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
20.5
11.2
16
8
A10AE05
ATC
insulin detemir; parenteral
3.5
11.2
53
163
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.5
11.0
28
45
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
10.9
81
335
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.3
10.7
39
95
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.9
10.7
66
245
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
10.6
45
126
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
3.2
10.6
57
193
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.4
10.3
93
426
A46
ICD-10 Finland
Erysipelas
2.2
10.3
111
556
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
10.1
77
324
V03AE02
ATC
sevelamer; oral
10.9
9.8
18
17
M04AA01
ATC
allopurinol; systemic
2.1
9.7
129
705
A10BB01
ATC
glibenclamide; oral
2.6
9.7
74
311
WX890
NOMESCO Finland
Intesive care monitoring
8.0
9.7
21
27
137
Kela drug reimbursment
Uraemia requiring dialysis
10.3
9.6
18
18
C02AC05
ATC
moxonidine; oral
3.2
9.5
50
167
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
5.0
9.4
29
60
L04AX01
ATC
azathioprine; systemic
5.0
9.4
29
60
V03AE03
ATC
lanthanum carbonate; oral
22.1
9.4
13
6
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
3.6
9.2
40
115
XCK10
NOMESCO Finland
Photography of fundus of eye
2.4
9.1
83
382
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.2
9.0
27
54
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
6.2
9.0
23
38
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.9
264
1888
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
12.8
8.9
15
12
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
8.8
143
841
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.1
8.8
47
159
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.1
8.8
47
159
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
8.8
149
893
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.2
8.7
45
149
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
8.7
98
498
C08CA02
ATC
felodipine; oral
2.2
8.7
98
498
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
8.4
8.6
18
22
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
11.8
8.6
15
13
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
8.6
46
156
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.4
8.5
72
318
81
HP
Angiography of the heart and coronary arteries
2.3
8.5
78
362
I81
ICD-10 Finland
Portal vein thrombosis
20.3
8.5
12
6
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.5
8.3
66
285
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
8.3
90
452
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.8
8.3
34
94
I47.2
ICD-10 Finland
Ventricular tachycardia
4.5
8.2
28
65
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
8.2
38
116
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
4.8
8.2
26
56
C10AA01
ATC
simvastatin; oral
1.6
8.0
310
2364
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.2
8.0
29
72
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.4
7.9
37
114
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
13.2
7.9
13
10
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
7.8
24
50
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.3
7.8
21
594
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.3
7.7
27
65
11
HP
Coronary artery bypass surgery
3.5
7.6
34
101
N19
ICD-10 Finland
Unspecified kidney failure
3.0
7.6
43
150
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
7.6
48
181
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.0
7.6
15
17
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
10.2
7.6
14
14
1CX08
NOMESCO Finland
NA
10.2
7.6
14
14
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.8
7.6
48
182
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
7.5
54
220
S97
ICPC
Chronic ulcer skin
2.7
7.4
49
191
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.8
7.4
16
21
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
7.0
7.3
17
25
AN2
HP
Balloon angioplasty, including several vessels
3.5
7.3
32
94
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
7.3
7
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.5
7.3
20
37
J15.8
ICD-10 Finland
Other bacterial pneumonia
12.2
7.1
12
10
Z49.2
ICD-10 Finland
Other dialysis
8.9
7.1
14
16
H3603, E103
ICD-10 Finland
NA
10.2
7.1
13
13
ZXE90
NOMESCO Finland
More than 22 hours
7.1
7.0
16
23
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
7.0
87
460
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
7.0
55
1032
AP1
HP
Catheterization of the left side of the heart
4.6
7.0
23
52
I20.01
ICD-10 Finland
Unstable angina
3.2
7.0
35
114
CKC10
NOMESCO Finland
Local photocoagulation of retina
4.3
7.0
24
57
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.3
7.0
65
303
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.2
7.0
68
326
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.0
6.9
26
67
AA1
HP
Conventional CABG
3.9
6.9
27
72
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.2
6.9
35
115
WX702
NOMESCO Finland
Supraglottic ventilation device
3.5
6.9
31
93
C07AB02
ATC
metoprolol; systemic
1.7
6.8
185
1267
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.1
6.8
35
117
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
40.5
6.8
8
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
16.9
6.8
10
6
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.3
6.7
31
96
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.3
6.7
23
55
B03XA01
ATC
erythropoietin; parenteral
6.5
6.7
16
25
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.7
6.7
27
75
H05BX01
ATC
cinacalcet; oral
7.9
6.6
14
18
AN3
HP
Balloon angioplasty and metallic stent
3.1
6.6
34
114
J01FF01
ATC
clindamycin; systemic
1.7
6.6
143
920
R41.0
ICD-10 Finland
Disorientation, unspecified
3.0
6.6
35
120
E87.5
ICD-10 Finland
Hyperkalaemia
4.2
6.6
23
56
C09BA02
ATC
enalapril and diuretics; systemic
2.1
6.5
75
383
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
6.4
102
590
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
6.4
30
94
I50
ICD-10 Finland
Heart failure
2.7
6.3
42
165
H3601, E103
ICD-10 Finland
NA
11.2
6.3
11
10
B05DB
ATC
Hypertonic solutions
9.4
6.3
12
13
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
18.2
6.3
9
5
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.4
6.3
50
216
TK810
NOMESCO Finland
Hemofiltration
7.1
6.2
14
20
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
26.9
6.2
8
*
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.5
6.2
47
198
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.4
6.2
17
32
A07AA09
ATC
vancomycin; oral
5.8
6.2
16
28
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.7
6.1
40
156
UJD02
NOMESCO Finland
Gastroscopy
2.9
6.1
35
125
B05DA
ATC
Isotonic solutions
8.7
6.1
12
14
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
6.1
62
304
H02AB06
ATC
prednisolone; systemic
1.5
6.0
256
1948

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
173
448
4.89
63.63
20.1
6.5
mmol/l
15.0
11.7
4.74
167
419
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
186
594
3.98
50.84
14.2
6.2
kpa
5.2
5.1
1.13
171
562
(3027801) Oxygen [Partial pressure] in Arterial blood
185
595
3.94
49.97
14.3
6.1
kpa
10.0
11.4
4.42
169
563
(3003458) Phosphate [Moles/volume] in Serum or Plasma
195
652
3.83
49.76
18.5
5.0
mmol/l
1.2
1.0
7.63
187
597
(3003396) Base excess in Arterial blood by calculation
184
595
3.91
49.24
14.4
6.2
mmol/l
2.4
1.4
1.71
137
454
(3016502) Oxygen saturation in Arterial blood
159
541
3.56
38.59
15.6
6.4
%
94.1
95.0
0.95
150
516
(3012095) Magnesium [Moles/volume] in Serum or Plasma
190
765
3.09
34.60
5.9
3.0
mmol/l
0.8
0.8
2.31
181
706
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
81
184
4.88
33.91
4.0
2.4
u/ml
0.3
0.3
0.65
50
106
(3019060) Gas panel - Arterial blood
119
367
3.74
33.17
13.5
3.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
53
8.39
31.42
9.2
5.7
iu/ml
390.5
238.9
—
11
7
(3002032) Base excess in Venous blood by calculation
141
506
3.28
30.90
8.8
3.6
mmol/l
2.2
2.0
0.34
113
390
(3024928) Oxygen saturation in Venous blood
58
107
5.85
30.58
6.6
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
181
760
2.91
30.09
6.6
2.4
g/l
2.2
2.2
1.09
168
686
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
174
718
2.94
29.84
6.9
2.4
%
21.1
21.4
0.06
133
616
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
94
265
3.97
29.67
22.3
8.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
139
511
3.18
29.14
8.9
3.6
kpa
5.8
5.8
0.11
127
492
(3008152) Bicarbonate [Moles/volume] in Arterial blood
108
342
3.58
28.74
18.2
5.1
mmol/l
25.3
24.4
1.17
103
316
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
135
508
3.09
27.06
5.6
3.1
ng/l
540.1
253.2
4.42
123
467
(3022948) Iron [Moles/volume] in Serum or Plasma
182
828
2.66
25.43
6.8
2.4
umol/l
10.9
11.8
0.48
174
751
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
107
369
3.27
24.72
8.9
3.8
ng/l
199.1
97.3
2.51
100
316
(3018572) Chloride [Moles/volume] in Blood
55
121
4.87
23.77
22.7
4.7
mmol/l
104.6
104.9
0.16
49
107
(3039000) Anion gap in Blood
55
121
4.87
23.77
22.7
4.7
mmol/l
11.6
11.4
0.12
49
107
(3047181) Lactate [Moles/volume] in Blood
64
160
4.32
23.61
21.8
4.7
mmol/l
1.4
1.4
0.03
59
140
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
200
1021
2.38
21.35
7.8
4.0
ng/l
452.6
218.3
1.00
179
876
(3023368) Bacteria identified in Blood by Culture
260
1510
2.20
20.17
7.6
4.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
91
322
3.12
19.98
7.2
3.1
g/l
112.2
124.2
5.32
86
314
(3000991) Gas panel - Venous blood
106
414
2.86
19.51
16.6
7.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
77
252
3.33
19.21
9.6
3.8
mmol/l
24.4
24.0
0.49
69
228
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
79
263
3.28
19.17
11.9
9.0
mmol/l
24.6
24.7
0.04
71
241
(3007930) Methemoglobin/Hemoglobin.total in Blood
72
230
3.39
18.66
18.3
3.9
%
0.9
0.9
0.05
64
213
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
72
230
3.39
18.66
18.3
3.8
%
1.9
1.6
3.08
62
213
(44790048)
25
32
8.08
18.38
1.6
1.4
—
—
—
0
0
(44806118)
25
32
8.08
18.38
1.6
1.4
—
—
—
0
0
(44790049)
25
32
8.08
18.38
1.6
1.4
—
—
—
0
0
(44790047)
25
32
8.08
18.38
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
134
613
2.49
17.91
2.0
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
133
618
2.44
17.13
2.2
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
103
431
2.65
16.48
6.2
3.0
kpa
5.6
4.4
4.00
92
412
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
96
391
2.70
16.19
2.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
93
4.51
16.13
1.6
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
67
225
3.20
15.98
3.7
1.9
ug/l
8.2
3.1
0.46
62
183
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
89
4.47
15.19
1.5
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
74
273
2.93
14.99
2.5
1.8
g/l
1.5
1.6
0.18
65
237
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
45
123
3.85
14.67
5.9
2.4
mg/l
2.5
1.9
2.92
40
109
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
24
8.12
14.07
1.1
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
96
422
2.49
13.78
13.1
6.6
mmol/l
1.4
1.5
0.34
88
401
(3018677) aPTT in Platelet poor plasma by Coagulation assay
150
798
2.14
13.76
4.0
1.9
s
30.8
30.1
0.94
144
764
(3011648) Oxygen content in Venous blood
21
31
6.96
13.64
3.0
1.6
%
10.1
10.2
0.04
21
31
(3021901) Oxygen saturation in Capillary blood
41
111
3.87
13.54
3.8
2.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
7
26.36
13.42
7.7
7.9
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
18
7
26.36
13.42
15.3
11.4
mmol/l
5.6
6.8
—
18
7
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
161
892
2.07
13.22
2.4
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
122
607
2.24
13.19
6.2
3.6
u/l
262.8
246.6
0.74
116
572
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
27
7.21
12.75
2.2
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
67
4.64
12.71
1.4
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
70
274
2.74
12.68
7.3
3.3
mmol/l
24.4
24.9
0.36
65
267
(40768446) Kidney Pathology biopsy report
17
7
24.85
12.51
2.4
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
335
2.54
12.19
3.3
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
45
140
3.38
12.12
3.7
2.3
kpa
7.6
7.8
0.25
45
125
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
6
27.26
12.09
8.1
7.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
62
4.67
11.98
2.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
129
685
2.10
11.74
3.4
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
295
3883
0.56
11.67
44.0
16.6
ml/min/173m2
54.9
71.9
16.50
252
3243
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
44
5.38
11.60
1.2
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
42
134
3.28
10.88
1.7
1.6
—
116.7
—
0
6
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
510
2.18
10.79
4.4
2.8
umol/l
7.3
9.4
1.09
87
451
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
455
2.24
10.76
3.2
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
77
4.03
10.67
10.3
3.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
98
487
2.19
10.52
5.8
2.3
e9/l
80.2
67.6
1.87
77
391
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
82
380
2.32
10.39
3.3
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
123
671
2.02
10.32
5.2
2.3
%
2.2
1.8
2.64
112
592
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
18
7.92
10.17
3.2
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
45
156
3.02
10.16
4.1
3.1
nmol/l
0.9
0.9
0.08
37
119
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
96
489
2.13
9.65
3.7
2.6
ug/l
6.7
5.9
0.28
88
409
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
11
11
10.15
9.56
3.6
1.9
%
84.2
99.0
0.45
11
11
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
57
4.33
9.44
1.6
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
380
4578
0.59
9.38
65.4
25.4
g/l
120.8
132.1
25.85
371
4474
(3010813) Leukocytes [#/volume] in Blood
380
4577
0.59
9.36
65.0
25.3
e9/l
8.1
7.0
3.04
365
4421
(3026361) Erythrocytes [#/volume] in Blood
380
4576
0.59
9.33
65.0
25.3
e12/l
4.1
4.4
14.35
367
4420
(3024731) MCV [Entitic volume]
380
4575
0.59
9.31
64.8
25.2
fl
91.5
91.7
0.37
371
4476
(3035941) MCH [Entitic mass]
380
4575
0.59
9.31
64.7
25.1
pg
30.0
30.4
4.97
370
4475
(3007461) Platelets [#/volume] in Blood
380
4574
0.59
9.28
65.2
25.2
e9/l
233.8
236.9
0.35
369
4436
(3007853) Bacteria identified in Skin by Aerobe culture
103
548
2.04
9.21
3.0
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
118
3.17
8.94
7.4
4.1
—
—
—
0
0
(3024471) HLA-A [Type]
12
5
24.37
8.93
1.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
79
3.66
8.75
7.5
2.2
%
71.1
60.2
1.64
28
79
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
32
5.42
8.71
1.1
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
70
328
2.27
8.63
7.0
3.6
mmol/l
1.6
2.0
0.30
54
239
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
57
4.14
8.58
1.3
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
12
6
20.32
8.49
9.0
7.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
62
3.98
8.48
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
76
3.66
8.47
1.5
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
313
3911
0.62
8.42
5.4
4.5
mmol/l
1.2
1.4
18.04
293
3496
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
58
4.07
8.39
1.6
1.1
u/ml
326.1
285.1
0.20
18
34
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
327
4038
0.62
8.28
5.7
4.9
mmol/l
6.5
6.1
3.40
294
3581
(3024932) HLA-DR beta [Type]
11
5
22.32
8.03
1.1
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
200
1359
1.68
8.03
3.0
2.2
mg/l
3.1
3.2
0.31
184
1137
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
60
3.93
8.02
1.6
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
360
4330
0.62
7.90
44.8
16.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
334
4084
0.63
7.86
6.0
5.1
mmol/l
2.2
2.5
8.21
312
3652
(3009343) pH of Capillary blood
71
348
2.17
7.85
7.1
3.5
ph
7.4
7.4
0.39
17
34
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
370
4408
0.63
7.59
20.4
10.5
u/l
28.9
24.5
1.60
355
4209
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
323
3956
0.64
7.40
5.5
4.5
mmol/l
4.0
4.4
9.05
301
3569
(3032080) INR in Blood by Coagulation assay
286
2159
1.58
7.33
22.0
11.6
inr
1.4
1.4
0.07
69
593
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
175
2.56
7.23
1.8
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
1735
1.59
7.22
6.3
3.2
ng/l
5925.3
2258.7
5.74
216
1506
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
5
20.26
7.15
1.0
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
311
2403
1.56
7.14
26.4
6.3
mmol/l
1.2
1.2
11.45
274
1987
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
118
2.89
7.10
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
118
2.89
7.10
1.5
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
137
2027
0.59
6.95
3.6
5.3
ug/l
2.5
3.7
1.20
117
1783
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
207
2.37
6.70
2.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
309
3782
0.65
6.67
5.1
4.1
mmol/l
1.5
1.2
6.17
287
3356
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
140
904
1.70
6.67
3.6
1.7
mg/l
1.8
1.4
0.74
116
722
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
285
2184
1.54
6.64
22.6
5.6
mmol/l
1.2
1.2
10.20
266
1932
(3023419) Bacteria identified in Sputum by Culture
20
55
3.72
6.51
1.9
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
137
2.64
6.38
1.9
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
245
1831
1.54
6.33
6.5
2.7
ug/l
244.1
156.7
2.18
234
1643
(3023103) Potassium [Moles/volume] in Serum or Plasma
380
4436
0.66
6.29
63.4
21.0
mmol/l
4.1
4.0
3.61
370
4301
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
181
2.41
6.28
3.3
3.4
mg/l
69.9
35.1
2.25
35
147
(3019550) Sodium [Moles/volume] in Serum or Plasma
380
4430
0.66
6.17
61.5
20.9
mmol/l
138.9
139.5
4.27
369
4292
(3020630) Protein [Mass/volume] in Serum or Plasma
82
463
1.88
6.12
2.9
2.6
g/l
64.9
65.6
0.30
76
406
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
73
3.23
6.06
1.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
23
5.29
6.02
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
188
1339
1.57
5.96
4.5
2.9
u/l
39.6
33.6
0.25
178
1280
(3034860) Kappa light chains.free [Mass/volume] in Serum
41
180
2.36
5.90
3.4
3.4
mg/l
95.6
98.4
0.03
34
144
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
64
3.35
5.90
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
106
1615
0.59
5.82
3.5
4.7
%
23.2
21.6
0.46
52
822
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
20
5.57
5.82
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
77
434
1.88
5.78
2.9
2.1
g/l
0.2
0.2
0.20
72
392
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
82
3.00
5.62
1.7
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
23
77
3.06
5.57
1.3
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
254
1953
1.49
5.57
10.2
5.1
%
2.6
2.8
0.99
242
1804
(3022096) Basophils/100 leukocytes in Blood
248
1905
1.48
5.43
10.3
5.1
%
0.6
0.6
0.53
236
1762
(1761868) Lipid panel - Serum or Plasma
71
1186
0.55
5.43
3.6
3.2
—
—
—
0
0
(3025315) Body weight
8
5
16.17
5.42
6.5
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
195
1426
1.52
5.41
9.0
4.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
254
1962
1.48
5.40
10.6
5.3
%
8.9
8.9
0.00
243
1825
(3019977) pH of Arterial blood
14
34
4.18
5.37
2.5
2.4
ph
7.4
7.4
—
5
8
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
48
3.61
5.35
1.4
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
70
393
1.87
5.32
3.2
2.5
u/l
34.7
32.4
0.24
60
327
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
34
144
2.43
5.31
1.6
2.0
u/l
32.6
38.8
0.81
29
125
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
68
1141
0.55
5.27
2.3
3.2
ug/l
1.1
0.8
0.54
48
784
(3018418) pH of Serum or Plasma
197
1452
1.51
5.24
13.0
3.9
ph
7.4
7.4
1.08
32
278
(3024561) Albumin [Mass/volume] in Serum or Plasma
272
2139
1.46
5.24
14.0
4.5
g/l
31.6
34.4
12.29
263
1963
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
14
35
4.06
5.18
1.4
1.1
u/l
51.8
53.0
—
9
23
(3018010) Neutrophils/100 leukocytes in Blood
253
1966
1.47
5.16
10.4
5.1
%
63.3
59.2
5.78
242
1824
(3037522) Nuclear Ab [Titer] in Serum
74
431
1.81
5.01
1.6
1.3
titre
722.5
427.0
0.45
16
89
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
194
2.19
4.99
1.6
2.3
g/l
3.4
3.2
0.55
28
146
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
77
2.92
4.96
1.2
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
210
2.12
4.84
1.6
2.3
g/l
4.4
3.7
1.23
28
143
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
211
2.11
4.79
1.6
2.3
g/l
8.0
7.5
0.73
29
148
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
211
2.11
4.79
1.6
2.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
254
2003
1.44
4.69
10.3
5.3
%
21.2
25.3
7.13
243
1845
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
21
4.82
4.54
1.1
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
196
2.11
4.48
1.7
2.3
g/l
10.9
10.2
0.51
30
161
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
323
3780
0.71
4.42
5.4
4.4
mu/l
2.2
2.0
1.75
298
3324
(40760888) Immunoglobulin light chains.free panel - Serum
30
131
2.35
4.42
4.0
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
372
4249
0.71
4.37
48.0
17.5
mg/l
31.8
27.4
1.75
352
3529
(3001604) Monocytes [#/volume] in Blood
256
2043
1.41
4.34
9.5
4.9
e9/l
0.7
0.6
3.71
227
1746
(3006315) Basophils [#/volume] in Blood
256
2053
1.40
4.19
9.5
5.0
e9/l
0.0
0.0
0.08
226
1766
(3026493) Urate [Moles/volume] in Serum or Plasma
165
1222
1.47
4.17
4.8
2.7
umol/l
7617.8
7443.8
0.01
153
1031
(3033799) Differential panel - Peritoneal fluid
9
13
7.00
4.17
2.3
2.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
13
7.00
4.17
2.6
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
13
7.00
4.17
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
47
3.24
4.07
1.2
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
259
2091
1.39
4.04
9.7
5.1
e9/l
1.7
1.8
0.56
231
1833
(3013115) Eosinophils [#/volume] in Blood
262
2122
1.39
4.00
10.6
5.1
e9/l
0.2
0.2
0.59
236
1848
(3004588) Protein electrophoresis panel - Serum or Plasma
64
383
1.74
3.98
2.7
2.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
2406
1.38
3.89
9.7
5.8
umol/l
13.1
12.2
0.49
281
2269
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
188
1445
1.42
3.86
4.8
2.4
u/l
61.2
57.6
0.19
181
1339
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
36
180
2.06
3.85
2.8
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
206
1615
1.40
3.77
4.3
3.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
341
3908
0.73
3.76
10.3
6.4
mmol/mol
45.6
41.2
7.81
319
3546
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
56
328
1.77
3.76
2.1
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
84
2.55
3.74
1.3
1.3
e6/l
483.2
1451.7
2.21
16
60
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
30
3.71
3.65
1.3
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
540
0.48
3.60
6.2
4.6
%
31.6
32.6
0.21
21
346
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
10
7.06
3.37
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
59
2.75
3.34
1.3
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
71
2.58
3.31
1.3
1.3
e6/l
27287.1
30006.9
0.06
12
44
(21494755) Public health laboratory ask at order entry panel
5
183
0.27
3.15
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
254
1.78
3.13
8.2
3.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
354
0.41
3.10
1.6
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
30
153
2.01
3.09
8.0
3.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
119
2.14
3.07
1.7
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
182
1440
1.36
3.07
5.9
3.9
mg/mmol
43.7
10.2
4.09
144
915
(3025941) Bacteria identified in Stool by Culture
40
226
1.82
3.05
1.3
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
146
1117
1.39
3.01
10.0
3.9
%
77.3
82.8
1.48
140
1089
(4281824)
11
35
3.18
2.94
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
174
1376
1.36
2.93
5.1
3.1
mmol/l
6.4
7.1
1.63
156
1115
(3037121) Protein [Mass/volume] in Urine
32
173
1.89
2.81
4.0
2.8
g/l
0.8
0.3
2.60
21
60
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
110
2.13
2.81
1.5
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
31
3.26
2.78
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
54
2.63
2.71
2.9
2.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
108
799
1.42
2.70
38.5
29.6
inr
1.6
1.5
0.23
15
100
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
169
1.87
2.67
1.8
2.4
g/l
34.5
36.6
1.20
26
136
(3012501) Base excess in Blood by calculation
24
120
2.04
2.63
11.7
4.9
mmol/l
2.6
2.6
0.03
17
79
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
25
3.63
2.58
3.2
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
181
0.33
2.57
1.0
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
7
7.18
2.55
1.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
108
808
1.40
2.53
5.2
3.2
e6/l
2.5
2.3
0.10
67
463
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
115
2.04
2.53
1.9
1.6
—
—
—
0
0
(3020891) Body temperature
35
202
1.77
2.53
11.1
3.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
33
3.06
2.53
1.8
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
281
2424
1.28
2.45
13.5
8.2
e9/l
4.9
4.4
3.47
252
2110
(3000850) Epithelial cells [#/volume] in Urine
141
1112
1.34
2.38
4.6
2.7
e6/l
5.3
4.8
0.28
127
973
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
40
2.78
2.38
1.3
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
46
2.64
2.36
1.6
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
65
2.34
2.32
1.2
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
180
1475
1.30
2.32
3.0
2.0
u/l
210.3
297.1
0.73
169
1373
(3012516) Albumin [Mass/volume] in Urine
167
1355
1.31
2.31
5.0
3.1
mg/l
715.0
305.0
0.54
136
881
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
35
2.88
2.31
1.9
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
561
0.60
2.27
16.2
8.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
66
2.30
2.25
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
76
546
1.44
2.24
5.6
4.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
128
1.91
2.24
2.0
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
9
5.58
2.21
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
109
836
1.36
2.21
4.1
3.0
e6/l
1.2
1.2
0.04
68
485
(4306422)
10
36
2.80
2.20
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
42
2.65
2.19
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
130
1615
0.76
2.16
2.3
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
30
3.03
2.15
1.2
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
75
2.16
2.09
1.4
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
31
2.93
2.07
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
96
2.01
2.07
1.6
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
314
2786
1.24
2.04
16.4
4.6
mmol/l
8.1
6.9
9.67
300
2614
(3043410) Blood group antigens tested for on Red Blood Cells
6
15
4.02
2.04
4.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
50
2.42
2.03
1.6
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
83
2.07
2.02
1.7
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
49
330
1.52
2.00
5.4
3.1
ml/min/173m2
37.9
57.8
3.57
27
149
(3013512) EKG study
115
1433
0.76
1.94
6.4
4.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
236
2040
1.24
1.92
8.9
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
132
1068
1.29
1.85
11.3
6.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
210
1798
1.25
1.85
6.2
3.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
18
325
0.54
1.84
2.6
2.1
nmol/l
12.4
12.2
0.03
18
281
(3017704) Immunofixation for Urine
9
35
2.59
1.80
1.8
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
29
2.78
1.79
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
60
2.19
1.78
1.6
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
18
3.35
1.75
1.5
1.1
u/l
65.3
102.8
—
6
12
(3009542) Hematocrit [Volume Fraction] of Blood
331
3628
0.82
1.74
48.8
18.9
%
35.4
38.5
4.66
189
2272
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
24
2.93
1.72
1.4
1.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
16
82
1.97
1.70
1.3
1.1
u/l
48.9
48.1
0.01
11
66
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
163
0.42
1.68
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
42
2.40
1.68
1.4
1.1
nmol/l
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
1.4
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
166
1407
1.24
1.58
5.5
3.3
e6/l
0.9
0.6
0.55
142
1084
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
50
2.22
1.57
1.3
1.1
u/ml
2.5
7.5
—
6
24
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
132
1093
1.26
1.54
5.4
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
274
3036
0.83
1.54
4.6
3.6
pmol/l
15.0
15.1
0.15
259
2641
(3044640) Blood type and Crossmatch panel - Blood
173
1477
1.23
1.54
5.3
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
130
1075
1.26
1.54
5.4
3.0
mosm/kgh2o
508.0
562.0
2.30
116
910
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
33
2.44
1.54
1.5
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
44
2.29
1.53
1.4
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
15
3.35
1.52
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
181
1555
1.23
1.52
6.4
3.5
e6/l
115.8
126.2
0.05
158
1226
(3002179) Metamyelocytes/100 leukocytes in Blood
43
301
1.46
1.51
6.4
3.7
%
1.5
0.4
2.10
11
86
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
65
2.02
1.49
5.6
1.8
pg
31.4
33.0
0.65
13
65
(3000494) Fungus identified in Specimen by Culture
64
483
1.36
1.48
2.0
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
155
1314
1.23
1.47
5.6
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
45
2.24
1.47
2.6
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
46
2.19
1.40
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
32
463
0.67
1.37
19.0
4.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
23
2.62
1.37
1.2
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.37
1.29
1.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
34
2.37
1.29
1.8
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.37
1.29
1.8
1.7
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
18
2.79
1.28
1.2
1.2
%
11.2
25.8
—
5
10
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
47
346
1.39
1.28
2.0
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
84
1.80
1.27
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
179
1.53
1.25
2.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
93
1.74
1.22
1.6
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
38
2.12
1.18
1.6
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
35
0.00
1.15
0.0
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
102
1207
0.82
1.11
7.0
4.5
estimate
0.0
0.0
0.50
27
385
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
31
2.27
1.10
2.3
2.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
31
2.27
1.10
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
8
41
1.96
1.09
1.4
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
41
1.96
1.09
17.4
2.9
umol/l
428.8
339.4
—
8
36
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
52
1.94
1.06
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
33
2.13
1.05
1.4
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
22
2.28
1.03
4.4
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
22
2.28
1.03
4.4
2.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
68
1.78
1.01
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
35
2.01
1.00
12.3
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
228
2496
0.87
0.99
5.2
3.1
u/l
70.8
56.6
1.48
215
2283
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
49
1.85
0.99
2.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
49
1.85
0.99
2.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
30
0.00
0.97
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
51
1.77
0.94
1.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
62
1.79
0.94
2.7
2.0
%
87.7
89.7
0.51
11
62
(40760892) CBC W Ordered Manual Differential panel - Blood
95
804
1.21
0.94
7.4
4.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
44
340
1.31
0.93
7.2
3.8
%
0.6
0.8
0.41
14
118
(3000012) Reticulocyte production index
6
28
2.15
0.91
3.2
1.9
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
28
2.15
0.91
3.3
2.2
mmol/l
8.9
7.5
—
6
21
(3018095) Leukocytes [#/volume] in Urine
192
1732
1.15
0.90
7.3
4.0
e6/l
66.9
168.4
1.47
162
1294
(3004451) EKG impression Narrative
6
29
2.08
0.89
1.5
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
42
1.91
0.88
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
153
1.45
0.86
2.1
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
240
1.35
0.83
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
47
1.71
0.81
2.6
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
152
1689
0.87
0.80
6.4
4.6
—
—
—
0
0
(44806420)
0
24
0.00
0.79
0.0
2.6
—
—
—
0
0
(4268621)
6
33
1.82
0.79
2.0
1.9
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
26
0.00
0.78
0.0
1.2
—
2.9
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
74
1.63
0.78
1.1
1.1
—
—
—
0
0
(4094501)
5
99
0.50
0.78
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
133
1181
1.16
0.77
2.0
1.8
nmol/l
1325.7
1179.3
0.75
112
881
(3003338) MCHC [Mass/volume]
317
3357
0.89
0.77
56.7
23.1
g/l
326.9
331.4
10.34
308
3313
(3051611) Lipemic interference index of Serum or Plasma
10
59
1.70
0.76
9.7
3.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(4034850)
8
133
0.60
0.74
8.4
10.6
—
—
—
0
0
(3044889) 12 lead EKG panel
290
3079
0.89
0.72
6.5
4.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
746
0.83
0.72
1.3
1.2
u/ml
0.9
1.3
0.63
12
190
(3021440) Promyelocytes/100 leukocytes in Blood
40
318
1.27
0.72
7.5
3.9
%
0.0
0.1
2.63
12
107
(3016018) Differential panel - Cerebral spinal fluid
5
26
1.93
0.70
1.4
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
299
3164
0.90
0.69
5.3
4.0
mm/h
23.0
14.8
8.52
277
2857
(3035320) C reactive protein [Mass/volume] in Body fluid
5
27
1.86
0.68
1.6
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
383
0.77
0.67
8.6
4.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
213
0.70
0.66
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
44
1.60
0.65
1.1
1.1
g/l
1.9
1.6
—
7
39
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
29
1.73
0.64
2.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
29
1.73
0.64
2.4
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
306
1.26
0.63
7.9
3.9
%
0.2
0.1
0.09
11
92
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
176
0.68
0.63
1.1
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
49
1.64
0.62
2.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
49
1.64
0.62
2.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
50
1.61
0.61
2.5
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
8
50
1.61
0.61
1.6
1.3
iu/l
17.9
25.9
—
8
43
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
8.9
—
0
6
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
73
1.51
0.56
1.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
55
1.46
0.56
1.6
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
55
1.46
0.56
1.4
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
91
1.44
0.53
2.5
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
172
1.29
0.48
1.2
1.2
iu/ml
93.9
135.6
—
7
59
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
92
1019
0.89
0.48
4.0
3.2
mmol/l
2.5
2.5
0.54
76
869
(3003181) Sodium [Moles/volume] in Urine
14
102
1.38
0.47
1.1
1.2
mmol/l
54.2
62.5
0.41
14
85
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
428
0.83
0.47
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
48
1.46
0.47
3.9
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
192
2037
0.92
0.44
3.2
2.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
320
3323
0.93
0.43
56.1
21.2
%
15.0
14.0
19.09
310
3250
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
162
0.74
0.43
1.0
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
94
0.63
0.42
4.3
3.9
u/ml
17.2
425.7
—
6
86
(3016750) Collection duration of Urine
5
32
1.57
0.42
2.0
2.4
min
489.0
480.2
—
5
20
(3021960) Folate [Moles/volume] in Serum or Plasma
139
1291
1.10
0.41
1.8
1.6
nmol/l
18.5
20.1
0.55
124
1087
(3002523) Influenza virus A Ag [Presence] in Specimen
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
314
0.82
0.41
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
123
1.31
0.40
1.4
1.4
ug/g
285.4
267.0
—
9
62
(3003740) Influenza virus B Ag [Presence] in Specimen
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
183
1725
1.08
0.39
3.8
2.2
nmol/l
72.6
78.4
2.05
168
1490
(3049717) Cytology report of Urine Cyto stain
19
236
0.80
0.38
2.4
3.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
66
1.37
0.38
1.1
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
36
1.39
0.38
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
134
1.28
0.37
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
61
679
0.89
0.36
1.7
1.3
g/l
3.2
2.6
0.47
39
392
(3004775) Volume in Urine collected for unspecified duration
6
44
1.37
0.34
1.8
2.4
ml
434.0
564.5
—
6
25
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
136
1.26
0.33
1.1
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
87
0.69
0.33
1.3
1.6
nmol/l
52.8
46.0
—
6
81
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
74
1.36
0.32
2.4
2.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
205
2142
0.94
0.31
7.7
5.8
estimate
0.0
0.0
0.00
37
398
(42529406) Shigella sp [Presence] in Stool by Culture
17
138
1.24
0.30
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
208
2169
0.94
0.30
5.7
4.3
estimate
0.0
0.0
0.00
34
397
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
1008
0.92
0.29
2.4
1.6
mmol/l
1.7
1.3
2.61
89
822
(3015377) Calcium [Moles/volume] in Serum or Plasma
172
1638
1.07
0.29
5.4
3.2
mmol/l
2.3
2.3
1.61
158
1387
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
121
1.24
0.28
1.1
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
85
1.30
0.28
1.3
1.2
—
28.5
—
0
5
(3003694) ABO and Rh group [Type] in Blood
107
1003
1.08
0.28
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
132
1.22
0.25
1.9
2.4
ug/min
394.6
92.6
—
9
76
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
266
0.86
0.25
2.3
2.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
24
207
1.16
0.25
11.0
4.2
mmol/l
24.8
25.0
0.09
24
195
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
989
1.07
0.25
4.2
4.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
96
1.25
0.24
1.7
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
103
970
1.07
0.24
5.7
4.8
kg/l
1.0
1.0
0.19
19
162
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
215
2074
1.05
0.24
2.4
2.1
pmol/l
91.4
91.8
0.04
122
1106
(3004616) Nuclear Ab [Presence] in Serum
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(4146454)
5
41
1.22
0.22
3.0
2.8
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
41.0
—
0
11
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
10
123
0.81
0.20
6.2
4.2
mg/l
21.0
31.2
—
10
83
(40761535) Cells panel - Urine sediment
36
396
0.90
0.20
4.9
3.9
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
14
0.00
0.20
0.0
1.7
—
1.2
—
0
14
(3020650) Glucose [Presence] in Urine
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
112
1174
0.94
0.20
6.2
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
188
1817
1.05
0.19
23.6
9.9
e9/l
0.0
0.0
0.68
146
1484
(4010399)
24
269
0.89
0.18
1.6
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
59
1.19
0.18
1.7
1.1
u/l
10.7
7.3
—
7
46
(3031040) Bacteria [#/volume] in Urine by Automated count
314
3076
1.04
0.17
6.9
5.1
e6/l
9215.8
2421.9
—
6
71
(3022621) pH of Urine by Test strip
35
320
1.10
0.17
3.0
3.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
69
1.16
0.16
2.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
71
1.13
0.16
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
71
1.13
0.16
2.9
2.7
e9/l
4.7
4.7
—
8
71
(3035350) Ketones [Presence] in Urine by Test strip
209
2141
0.96
0.15
5.6
4.2
estimate
0.0
0.0
0.00
37
409
(3037467) Urinalysis macro (dipstick) panel - Urine
315
3093
1.03
0.15
7.0
4.6
—
—
—
0
0
(3002256) Pathology report gross observation
52
552
0.94
0.14
1.4
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
132
1.14
0.13
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
180
1.11
0.13
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
123
1.14
0.12
1.7
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
1147
1.03
0.10
1.9
1.8
pmol/l
444.1
10532470.5
0.79
108
921
(3026389) Candida sp identified in Specimen by Organism specific culture
6
57
1.05
0.08
2.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.2
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
61
0.82
0.08
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
74
0.81
0.07
1.2
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
74
1.08
0.07
5.6
3.3
%
59.9
60.8
—
8
74
(3000492) Spirometry study
34
323
1.05
0.07
1.4
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
340
3428
0.98
0.07
14.8
7.2
u/l
95.1
82.0
1.03
324
3184
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
89
1.12
0.06
1.5
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
19
177
1.07
0.06
5.3
5.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
51
525
0.97
0.05
1.3
1.2
u/ml
7.9
8.9
0.08
23
186
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
535
0.97
0.05
4.0
4.1
ug/l
4.6
31.2
1.14
45
455
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
206
2037
1.02
0.05
8.2
4.2
ng/l
141.8
68.3
0.81
160
1577
(40768797) Stomach Pathology biopsy report
56
545
1.03
0.04
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
199
1.06
0.04
3.6
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
553
0.97
0.04
1.3
1.2
iu/ml
150.8
39.0
0.67
21
178
(3014051) Protein [Presence] in Urine by Test strip
11
102
1.08
0.03
2.6
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
43
421
1.02
0.02
1.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
28
273
1.03
0.01
4.8
4.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
184
1.03
0.00
2.5
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
194
1.03
0.00
1.1
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
100
1.00
0.00
1.1
1.3
—
—
—
0
0
(4035726)
36
365
0.98
0.00
1.9
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
222
0.99
0.00
3.6
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
57
0.88
0.00
1.4
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
14.0
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PULMOEDEMA and mortality.

Females

Parameter HR [95% CI] p-value
J10_PULMOEDEMA 3.634 [3.06, 4.32] < 0.001
Birth year 0.996 [0.99, 1.01] 0.435

During the follow-up period (1.1.1998 — 31.12.2019), 1992 out of 2704 females with J10_PULMOEDEMA died.

Males

Parameter HR [95% CI] p-value
J10_PULMOEDEMA 4.391 [3.53, 5.47] < 0.001
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1713 out of 2356 males with J10_PULMOEDEMA died.

Mortality risk

Mortality risk for people of age

years, who have J10_PULMOEDEMA.

N-year risk Females Males
1 0.404% 0.926%
5 2.256% 4.818%
10 5.214% 12.463%
15 10.119% 22.504%
20 17.492% 35.623%

Relationships between endpoints

↥

Index endpoint: J10_PULMOEDEMA – Pulmonary oedema

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data